Orange, CA, United States of America

Parvin Mahdipoor

This inventor holds 1 USPTO granted patent. Top assignee: Chapman University. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Parvin Mahdipoor. Retrieved from https://idiyas.com/inventor/parvin-mahdipoor

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Parvin Mahdipoor: Innovator in Targeted Drug Delivery Systems

Introduction

Parvin Mahdipoor is a notable inventor based in Orange, California. He has made significant contributions to the field of drug delivery systems, particularly in the development of targeted peptide-drug conjugates. His innovative work aims to enhance the efficacy of chemotherapeutic agents in cancer treatment.

Latest Patents

Parvin Mahdipoor holds 1 patent for his invention titled "Targeted peptide-drug conjugates." This patent describes drug delivery systems that combine a peptide targeting agent with a pharmaceutical agent. The systems are designed for the effective delivery of chemotherapeutic agents, providing new methods for treating cancer through the administration of these advanced drug delivery systems.

Career Highlights

Parvin is affiliated with Chapman University, where he contributes to research and development in the field of drug delivery. His work is characterized by a commitment to improving cancer treatment methodologies through innovative approaches.

Collaborations

Parvin collaborates with esteemed colleagues, including Saghar Mozaffari and Rakesh Tiwari. Their combined expertise fosters a productive research environment that enhances the potential for groundbreaking discoveries in drug delivery systems.

Conclusion

Parvin Mahdipoor's contributions to targeted drug delivery systems represent a significant advancement in cancer treatment. His innovative approach and collaboration with fellow researchers position him as a key figure in the ongoing quest for effective therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…